Global Markets for Treatments for Syndromes of Dementia and Movement Disorders

Published - Sep 2012| Code - PHM117A| Analyst - Shalini Shahani Dewan

Report Highlights

The global market for treatments for syndromes of dementia and movement disorders was valued at 10.5 billion in 2011 and should reach $11.1 billion in 2012. Total market value is expected to reach $16.7 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 8.5%.

SCOPE OF THE STUDY

The scope of this study encompasses the neurodegenerative disorders in the pharmaceutical and biotechnology markets.  BCC analyzes each market and its applications, regulatory environment, technology involved, market projections and market share.  Technological issues include the latest trends and developments.  The emerging market for enzyme inhibitors includes countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia, New Zealand and Mexico.

Analyst Credentials

Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.

Latest reports include:

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
Title/Chapter Name Pages Price Member Price
Full Report: Global Markets for Treatments for Syndromes of Dementia and Movement Disorders 228 $2,750 Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: EXECUTIVE SUMMARY2$250Free
Chapter- 3: OVERVIEW10$121Free
Chapter- 4: REGULATORY ASPECTS5$60Free
Chapter- 5: NEW DEVELOPMENTS19$229Free
Chapter- 6: GLOBAL MARKETS13$157Free
Chapter- 7: MARKET FOR DRUG PRODUCTS USED TO TREAT PROGRESSIVE DEMENTIA32$386Free
Chapter- 8: MARKET FOR DRUGS TO TREAT PROGRESSIVE DEMENTIA WITH OTHER NEUROLOGICAL ABNORMALITIES24$289Free
Chapter- 9: MARKET FOR MOVEMENT DISORDER SYNDROMES35$422Free
Chapter- 10: PATENT ANALYSIS20$241Free
Chapter- 11: CURRENT SITUATION7$84Free
Chapter- 12: COMPANY PROFILES55$663Free
Chapter- 13: APPENDIX I: ABBREVIATIONS3$36Free
RELATED REPORTS
Share This Report